Table 1.

Cumulative results of all mice inoculated with either CT26 and ID8-VEGF tumors.

Treatment Groups	CT26	ID8-VEGF
Control IgG	0	0
αPD-1	25	25
αPD-L1	33	37.5
αCTLA-4	50	25
αPD-1+αCTLA-4	75*	50
αPD-L1+αCTLA-4	75*	50
GVAX	0	0
GVAX + αPD-1	42	37.5
GVAX + αPD-L1	50	50
GVAX + αCTLA-4	75*	37.5
GVAX + αPD-1+ αCTLA-4	100*	75**
GVAX + αPD-L1+ αCTLA-4	100*	75**

p values among different treatments were calculated using the log-rank test

^*P ≤ 0.05;

^**P ≤ 0.01.